Sun Pharmaceutical completes merger with Taro Pharmaceutical to enhance market position
Sun Pharmaceutical Industries Limited has announced the completion of its strategic merger with Taro Pharmaceutical Industries Ltd. (NYSE: TARO), marking a significant consolidation in the ... Read More
Sun Pharmaceutical proposes revised offer for Taro Pharmaceutical acquisition
In a notable development within the pharmaceutical industry, Sun Pharmaceutical Industries Limited has expressed a non-binding interest in acquiring shares of Taro Pharmaceutical Industries Ltd. ... Read More
Sun Pharmaceutical subsidiary acquires Alchemee business from Galderma
Sun Pharmaceutical Industries said that its subsidiary Taro Pharmaceutical Industries’ fully-owned subsidiary Taro Pharmaceuticals U.S.A., has acquired Delaware-based Galderma Holdings, Japan-based Proactiv YK, Canada-based The ... Read More
Taro Pharmaceutical ends licensing agreement with NovaBiotics over Novexatin failure
Taro Pharmaceutical Industries has terminated its licensing agreement with Scottish biotech company NovaBiotics concerning the Novexatin drug after disappointing clinical trial results. The decision follows ... Read More